These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11158005)

  • 21. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
    Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree.
    Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
    J Clin Endocrinol Metab; 2000 May; 85(5):2014-9. PubMed ID: 10843190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.
    Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ
    Diabetes; 2003 Jul; 52(7):1864-71. PubMed ID: 12829658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.
    Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Auwerx J; Deeb SS; Amouyel P
    Int J Obes Relat Metab Disord; 2000 Feb; 24(2):195-9. PubMed ID: 10702770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity.
    Hsueh WC; Cole SA; Shuldiner AR; Beamer BA; Blangero J; Hixson JE; MacCluer JW; Mitchell BD
    Diabetes Care; 2001 Apr; 24(4):672-7. PubMed ID: 11315829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.
    Oh EY; Min KM; Chung JH; Min YK; Lee MS; Kim KW; Lee MK
    J Clin Endocrinol Metab; 2000 May; 85(5):1801-4. PubMed ID: 10843155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans.
    Cole SA; Mitchell BD; Hsueh WC; Pineda P; Beamer BA; Shuldiner AR; Comuzzie AG; Blangero J; Hixson JE
    Int J Obes Relat Metab Disord; 2000 Apr; 24(4):522-4. PubMed ID: 10805513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanocortin-3 receptor gene variants in a Maori kindred with obesity and early onset type 2 diabetes.
    Wong J; Love DR; Kyle C; Daniels A; White M; Stewart AW; Schnell AH; Elston RC; Holdaway IM; Mountjoy KG
    Diabetes Res Clin Pract; 2002 Oct; 58(1):61-71. PubMed ID: 12161058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.
    Evans D; de Heer J; Hagemann C; Wendt D; Wolf A; Beisiegel U; Mann WA
    Exp Clin Endocrinol Diabetes; 2001; 109(3):151-4. PubMed ID: 11409297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.
    Li S; Chen W; Srinivasan SR; Boerwinkle E; Berenson GS;
    Diabetes; 2003 May; 52(5):1265-9. PubMed ID: 12716762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes.
    Pollex RL; Mamakeesick M; Zinman B; Harris SB; Hegele RA; Hanley AJ
    J Diabetes Complications; 2007; 21(3):166-71. PubMed ID: 17493550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study.
    Snitker S; Watanabe RM; Ani I; Xiang AH; Marroquin A; Ochoa C; Goico J; Shuldiner AR; Buchanan TA;
    Diabetes Care; 2004 Jun; 27(6):1365-8. PubMed ID: 15161789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.
    Yen CJ; Beamer BA; Negri C; Silver K; Brown KA; Yarnall DP; Burns DK; Roth J; Shuldiner AR
    Biochem Biophys Res Commun; 1997 Dec; 241(2):270-4. PubMed ID: 9425261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Rettig A; Renn W; Häring HU
    Exp Clin Endocrinol Diabetes; 2000; 108(5):341-6. PubMed ID: 10989952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus.
    Evans D; Aberle J; Wendt D; Wolf A; Beisiegel U; Mann WA
    J Mol Med (Berl); 2001 May; 79(4):198-204. PubMed ID: 11409711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
    González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
    Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.
    Memisoglu A; Hu FB; Hankinson SE; Manson JE; De Vivo I; Willett WC; Hunter DJ
    Hum Mol Genet; 2003 Nov; 12(22):2923-9. PubMed ID: 14506127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of the Genetic Polymorphisms in Transcription Factor 7-Like 2 and Peroxisome Proliferator-Activated Receptors- γ 2 with Type 2 Diabetes Mellitus and is Interaction with Obesity Status in Emirati Population.
    Al-Safar H; Hassoun A; Almazrouei S; Kamal W; Afandi B; Rais N
    J Diabetes Res; 2015; 2015():129695. PubMed ID: 26273662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes.
    Mori H; Ikegami H; Kawaguchi Y; Seino S; Yokoi N; Takeda J; Inoue I; Seino Y; Yasuda K; Hanafusa T; Yamagata K; Awata T; Kadowaki T; Hara K; Yamada N; Gotoda T; Iwasaki N; Iwamoto Y; Sanke T; Nanjo K; Oka Y; Matsutani A; Maeda E; Kasuga M
    Diabetes; 2001 Apr; 50(4):891-4. PubMed ID: 11289058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects.
    Nielsen EM; Hansen L; Echwald SM; Drivsholm T; Borch-Johnsen K; Ekstrøm CT; Hansen T; Pedersen O
    Pharmacogenetics; 2003 Jul; 13(7):417-23. PubMed ID: 12835617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.